A Case of Eltrombopag-Induced Thrombotic Microangiopathy Initiating Hemodialysis
Open Access
- 18 December 2024
- journal article
- case report
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e75947
Abstract
Thrombopoietin receptor agonists are used in addition to steroids for idiopathic thrombocytopenic purpura. A 55-year-old male with idiopathic thrombocytopenic purpura, treated with eltrombopag, developed a rapid decline in renal function following the increase in eltrombopag dose. Renal biopsy showed glomerular endothelial disorder and platelet thrombus, which suggested eltrombopag-induced renal-limited thrombotic microangiopathy. He was treated with steroids; however, his renal function did not improve, and hemodialysis was initiated. During the treatment, acute myocardial infarction and arteriovenous fistula obstruction occurred. After that, he was subsequently diagnosed with antiphospholipid antibody syndrome. Eltrombopag can cause thrombotic microangiopathy and, in some cases, result in renal failure. Patients with idiopathic thrombocytopenic purpura coexisted with antiphospholipid antibody syndrome are at increased risk of thrombosis with thrombopoietin agonists and require careful follow-up.Keywords
This publication has 16 references indexed in Scilit:
- Acute kidney injury and nephrotic syndrome associated with eltrombopag therapy in chronic idiopathic thrombocytopenic purpuraBMJ Case Reports, 2021
- PostersNephrology, 2020
- Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysisScientific Reports, 2016
- Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled TrialsClinical and Applied Thrombosis/Hemostasis, 2016
- Thrombopoietin-Receptor Agonists for Immune ThrombocytopeniaNew England Journal of Medicine, 2011
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 studyThe Lancet, 2011
- Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopagAmerican Journal of Hematology, 2010
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Thrombopoietin-Induced Signal Transduction and Potentiation of Platelet ActivationThrombosis and Haemostasis, 1999
- Focal segmental glomerulosclerosis with acute renal failure associated with α-interferon therapyAmerican Journal of Kidney Diseases, 1996